Skip to content

Home
About Us
- Board of Directors
- Management Team
Technology
News/Resources
Investor Centre
Contacts

Key Phase 2 HIV/HCV trial commenced

28 April 20139 November 2012 by Karen Mobbs

Key Phase 2 HIV/HCV trial commenced

Categories 2012

Problem viruses can’t hide from new treatment — Ahead of the curve

Presentation of BIT225 Hepatitis C Virus 48-week data at AASLD conference, Boston MA

© Biotron Limited 2016 ABN 60 086 399 144 Site updated 29 November 2024 Legal Notices and Privacy